TOMM40 and Alzheimer disease: Additionally, a growing body of evidence has implicated Tomm40 polymorphisms as predictors of late onset AD (59–61) The extended regulatory region of TOMM40 in humans, which includes APOE and APOC2, has recently been reported to be hypomethylated in AD subjects correlated with its increased expression in AD (62).